Scientists have moved closer to developing a new class of effective asthma and allergy drugs. They have found an important target that holds significant promise for millions of people suffering from allergies, asthma, rheumatoid arthritis and a range of other inflammatory diseases. This work confirms that a key component of the body’s own response to allergens can be targeted to reduce allergic reactions in mice.